Dexfenfluramine (Redux) was a weight-loss drug that was approved by the U.S. Food and Drug Administration (FDA) in 1996. It was prescribed along with a low-fat diet and exercise program to treat obesity. The drug worked by suppressing appetite and reducing cravings. However, in 1997, the FDA withdrew its approval after reports of heart valve damage among some users. This resulted in the discontinuation of the drug.
Dexfenfluramine, once marketed under the brand name Redux, was a medication used for a short period in the 1990s for weight loss. Here's a breakdown of its key points:
What it does: Dexfenfluramine belonged to a class of drugs called serotonergic anorectics. It worked by influencing serotonin levels in the brain, which can lead to feelings of fullness and decreased appetite.
How it worked: It increased the amount of serotonin available in the brain by acting in two ways:
- Inhibiting the reuptake of serotonin: This means it prevented serotonin from being reabsorbed by nerve cells, keeping it active for longer.
- Stimulating the release of serotonin: It triggered the release of more serotonin from storage areas in the brain.
Why it was withdrawn: Although initially approved by the FDA, dexfenfluramine was later withdrawn from the market due to concerns about serious side effects. These included:
- Heart valve damage: Studies linked dexfenfluramine use to an increased risk of developing abnormalities in heart valves.
Current status: Dexfenfluramine is no longer a recommended treatment for obesity due to the withdrawn approval and the availability of safer alternatives.
Safer alternatives: If you're looking for weight loss support, it's important to talk to your doctor about safer and more effective options. These might include lifestyle changes like diet and exercise, or medications currently approved for weight management.